Clinical Trial Update: Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial updates the switch from didanosine to tenofovir in HIV/HCV co-infected patients, with follow-up on safety and virologic outcomes aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Videx (didanosine)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: University of British Columbia | Conditions: HIV, HIV Infections | Phase 4 | Status: COMPLETED